全文获取类型
收费全文 | 2468篇 |
免费 | 107篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 52篇 |
妇产科学 | 7篇 |
基础医学 | 257篇 |
口腔科学 | 107篇 |
临床医学 | 136篇 |
内科学 | 665篇 |
皮肤病学 | 41篇 |
神经病学 | 74篇 |
特种医学 | 89篇 |
外科学 | 531篇 |
综合类 | 8篇 |
预防医学 | 106篇 |
眼科学 | 26篇 |
药学 | 176篇 |
中国医学 | 4篇 |
肿瘤学 | 267篇 |
出版年
2023年 | 10篇 |
2022年 | 22篇 |
2021年 | 36篇 |
2020年 | 13篇 |
2019年 | 23篇 |
2018年 | 29篇 |
2017年 | 39篇 |
2016年 | 34篇 |
2015年 | 54篇 |
2014年 | 80篇 |
2013年 | 81篇 |
2012年 | 146篇 |
2011年 | 176篇 |
2010年 | 88篇 |
2009年 | 93篇 |
2008年 | 151篇 |
2007年 | 187篇 |
2006年 | 184篇 |
2005年 | 203篇 |
2004年 | 166篇 |
2003年 | 179篇 |
2002年 | 177篇 |
2001年 | 48篇 |
2000年 | 34篇 |
1999年 | 41篇 |
1998年 | 32篇 |
1997年 | 25篇 |
1996年 | 16篇 |
1995年 | 13篇 |
1994年 | 21篇 |
1993年 | 17篇 |
1992年 | 12篇 |
1991年 | 19篇 |
1990年 | 11篇 |
1989年 | 23篇 |
1988年 | 13篇 |
1987年 | 14篇 |
1986年 | 11篇 |
1985年 | 11篇 |
1984年 | 6篇 |
1983年 | 4篇 |
1982年 | 4篇 |
1981年 | 8篇 |
1980年 | 6篇 |
1979年 | 3篇 |
1978年 | 8篇 |
1977年 | 5篇 |
1974年 | 2篇 |
1971年 | 4篇 |
1968年 | 3篇 |
排序方式: 共有2591条查询结果,搜索用时 15 毫秒
91.
Kazuhira Endo Akira Tsuji Satoru Kondo Naohiro Wakisaka Shigeyuki Murono Tomokazu Yoshizaki 《Acta oto-laryngologica》2015,135(8):846-852
Conclusion: Longitudinal assessments of carnitine and fatigue in patients with head and neck squamous cell carcinoma suggest that cisplatin damages the carnitine system in patients undergoing chemoradiotherapy and that carnitine deficiency increases fatigue. Objectives: The purpose of this study was to monitor carnitine levels and fatigue in patients who received cisplatin-based CRT and, for comparison, in patients treated by surgery alone. Methods: To investigate the level of carnitine, mice were administered cisplatin. Next, a prospective analysis was performed to compare plasma carnitine levels before and after cisplatin-based chemoradiotherapy and to assess the relationship between carnitine levels and fatigue. Results: The plasma levels of total carnitine (TC), free carnitine (FC), and fatty acylcarnitine (AC) were significantly lower in mice receiving cisplatin compared with control mice. Mean total carnitine and free carnitine levels were significantly lower 2 weeks after chemoradiotherapy (total carnitine: Mean = 45.6, SD = 16.5, p = 0.01; free carnitine: Mean = 37.8, SD = 12.7, p = 0.02) than before chemoradiotherapy (total carnitine: Mean = 57.7, SD = 12.2; free carnitine: Mean = 48.1, SD = 11.6). There was a significant inverse correlation between carnitine levels and fatigue after chemoradiotherapy. 相似文献
92.
Kawasaki T Akakabe Y Yamano M Miki S Kamitani T Kuribayashi T Sugihara H 《Journal of electrocardiology》2008,41(1):68-71
Background and Purpose
R-wave amplitude change during exercise has been reported to enhance diagnostic value for myocardial ischemia in coronary heart disease.Methods
We summed up R-wave amplitude in all the 12 leads during exercise testing and correlated the results with regional myocardial ischemia or diffuse subendocardial ischemia as detected by scintigraphy in 49 patients with hypertrophic cardiomyopathy (HCM) and 16 controls.Results
The sum of R-wave amplitude decreased during exercise in patients with HCM (mean, 12.4 mV to 11.7 mV, P < .01) as well as in controls (8.0 mV to 7.7 mV, P < .05). Percent changes in the sum of R-wave amplitude did not differ between 4 subgroups of patients with HCM: one having both regional and subendocardial ischemia, one only the former, one only the latter, and one neither of them (mean, 6.5%, 7.7%, 4.6%, and 5.1%; P = .79).Conclusions
R-wave amplitude response to exercise failed to demonstrate myocardial ischemia in our patients with HCM. 相似文献93.
Kurokawa Y Matoba R Takemasa I Nakamori S Tsujie M Nagano H Dono K Umeshita K Sakon M Ueno N Kita H Oba S Ishii S Kato K Monden M 《Journal of hepatology》2003,39(6):1004-1012
BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) usually develops following chronic liver inflammation caused by hepatitis C or B virus. Through expression profiling in a rare type of HCC, for which the causes are unknown, we sought to find key genes responsible for each step of hepatocarcinogenesis in the absence of viral influence. METHODS: We used 68 non-B, non-C liver tissues (20 HCC, 17 non-tumor, 31 normal liver) for expression profiling with PCR-array carrying 3072 genes known to be expressed in liver tissues. To select the differentially expressed genes, we performed random permutation testing. A weighted voting classification algorithm was used to confirm the reliability of gene selection. We then compared these genes with the results of previous expression profiling studies. RESULTS: A total of 220 differentially expressed genes were selected by random permutation tests. The classification accuracies using these genes were 91.8, 92.0 and 100.0% by a leave-one-out cross-validation, an additional PCR-array dataset and a Stanford DNA microarray dataset, respectively. By comparing our results with previous reports on virus-infected HCC, four genes (ALB, A2M, ECHS1 and IGFBP3) were commonly selected in some studies. CONCLUSIONS: The 220 differentially expressed genes selected by PCR-array are potentially responsible for hepatocarcinogenesis in the absence of viral influence. 相似文献
94.
95.
Endoscopic removal of a fish bone foreign body in the hypopharynx with the modified Killian's method
Observing the entire circumference of the hypopharynx is usually difficult because most of the area is anatomically closed in the resting state. The modified Killian's method, consisting of a combination of the modified Killian position, head torsion, and the Valsalva maneuver, is a recently proposed procedure to improve the endoscopic view of the hypopharynx. A fish bone, which was invisible under regular endoscopy but was identified by CT, was successfully observed and removed under the modified Killian's method in a 71-year-old female. This method can be applied to diagnose and treat benign hypopharyngeal disease such as fish bone foreign body in addition to the detection of cancer. 相似文献
96.
97.
Terumi Kamisawa Kazuichi Okazaki Shigeyuki Kawa Tetsuhide Ito Kazuo Inui Hiroyuki Irie Takayoshi Nishino Kenji Notohara Isao Nishimori Shigeki Tanaka Toshimasa Nishiyama Koichi Suda Keiko Shiratori Masao Tanaka Tooru Shimosegawa 《Journal of gastroenterology》2014,49(6):961-970
The standard treatment for autoimmune pancreatitis (AIP) is steroid therapy, although some patients improve spontaneously. Indications for steroid therapy in AIP patients are symptoms such as obstructive jaundice, abdominal pain, back pain, and the presence of symptomatic extrapancreatic lesions. Prior to steroid therapy, obstructive jaundice should be managed by biliary drainage, and blood glucose levels should be controlled in patients with diabetes mellitus. The recommended initial oral prednisolone dose for induction of remission is 0.6 mg/kg/day, which is administered for 2–4 weeks. The dose is then tapered by 5 mg every 1–2 weeks, based on changes in clinical manifestations, biochemical blood tests (such as liver enzymes and IgG or IgG4 levels), and repeated imaging findings (US, CT, MRCP, ERCP, etc.). The dose is tapered to a maintenance dose (2.5–5 mg/day) over a period of 2–3 months. Cessation of steroid therapy should be based on the disease activity in each case. Termination of maintenance therapy should be planned within 3 years in cases with radiological and serological improvement. Re-administration or dose-up of steroid is effective for treating AIP relapse. Application of immunomodulatory drugs is considered for AIP patients who prove resistant to steroid therapy. The prognosis of AIP appears to be good over the short-term with steroid therapy. The long-term outcome is less clear, as there are many unknown factors, such as relapse, pancreatic exocrine or endocrine dysfunction, and associated malignancy. 相似文献
98.
Kazuichi Okazaki Shigeyuki Kawa Terumi Kamisawa Tetsuhide Ito Kazuo Inui Hiroyuki Irie Takayoshi Nishino Kenji Notohara Isao Nishimori Shigeki Tanaka Toshimasa Nishiyama Koichi Suda Keiko Shiratori Masao Tanaka Tooru Shimosegawa 《Journal of gastroenterology》2014,49(4):567-588
Background
In response to the proposal of the international consensus diagnostic criteria (ICDC) for autoimmune pancreatitis (AIP) and the Japanese diagnostic criteria in 2011, the 2009 Japanese consensus guidelines for managing AIP required revision.Methods
Three committees [the professional committee for making clinical questions (CQs) and statements by Japanese specialists, the expert panelist committee for rating statements by the modified Delphi method, and the evaluating committee by moderators] were organized. Fifteen specialists for AIP extracted the specific clinical statements from 1,843 articles published between 1963 and 2012 (obtained from Pub Med and a secondary database, and developed the CQs and statements. The expert panel individually rated the clinical statements using a modified Delphi approach, in which a clinical statement receiving a median score greater than seven on a nine-point scale from the panel was regarded as valid.Results
The professional committee created 13 CQs and statements for the current concept and diagnosis of AIP, 6 for extra-pancreatic lesions, 6 for differential diagnosis, and 11 for treatment.Conclusion
After evaluation by the moderators, amendments to the Japanese consensus guidelines for AIP have been proposed for 2013. 相似文献99.
Tetsuji Moriya Masatsugu Hamaji Akihiko Yoshizawa Ryo Miyata Misa Noguchi Shigeyuki Tamari Naohisa Chiba Hideaki Miyamoto Toshiya Toyazaki Satona Tanaka Yoshito Yamada Yojiro Yutaka Daisuke Nakajima Akihiro Ohsumi Toshi Menju Hiroshi Date 《Interactive Cardiovascular and Thoracic Surgery》2022,34(3):416
Open in a separate windowOBJECTIVESTo clarify survival outcomes and prognostic factors of patients receiving epidermal growth factor receptor (EGFR) - tyrosine kinase inhibitors (TKIs) as first-line treatment for postoperative recurrence.METHODSA retrospective chart review was performed to identify consecutive patients who received EGFR-TKIs as first-line treatment for postoperative recurrence of non-small-cell lung cancer (NSCLC) harbouring EGFR gene mutations at our institution between August 2002 and October 2020. Therapeutic response, adverse events, progression-free survival (PFS) and overall survival (OS) were investigated. Survival outcomes were assessed using the Kaplan–Meier analysis. The Cox proportional hazards model was used for univariable and multivariable analyses.RESULTSSixty-four patients were included in the study. The objective response and disease control rates were 53% and 92%, respectively. Grade 3 or greater adverse events were noted in 4 (6.3%) patients, including 1 patient (1.6%) of interstitial pneumonia. The median follow-up period was 28.5 months (range 3–202 months). The total number of events was 43 for PFS and 23 for OS, respectively. The median PFS was 18 months, and the median OS was 61 months after EGFR-TKI treatment. In multivariable analysis, osimertinib showed a tendency to prolong PFS [hazard ratio (HR) 0.41, 95% confidence interval (CI) 0.12–1.1; P = 0.071], whereas the micropapillary component was significantly associated with shorter OS (HR 2.1, 95% CI 1.02–6.9; P = 0.045).CONCLUSIONSEGFR-TKIs as first-line treatment appeared to be a reasonable treatment option in selected patients with postoperative recurrent EGFR-mutated NSCLC. Osimertinib and the micropapillary component may be prognostic factors. 相似文献